Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
Journal of Affective Disorders|September 1, 2024
Effects of ketamine on metabolic parameters in depressive disorders: A systematic reviewSabrina Wong, Gia Han Le, Rodrigo Mansur, et al.Journal of Affective Disorders|October 18, 2024
Impact of antidepressants on the composition of the gut microbiome: A systematic review and meta-analysis of in vivo studiesJann Gamboa, Gia Han Le, Sabrina Wong, et al.Journal of Affective Disorders|June 21, 2026
Investigating the effects of antidepressants on measures of insulin resistance in major depressive disorder: A systematic reviewSabrina Wong, Gia Han Le, Yang Jing Zheng, et al.Journal of Psychiatric Research|October 18, 2025
Efficacy and safety profiles of FDA-approved dual orexin receptor antagonists in depression: A systematic review of pre-clinical and clinical studiesShreya Vasudeva, Sabrina Wong, Gia Han Le, et al.Expert Opinion on Drug Metabolism & Toxicology|December 18, 2025
Abuse liability of dextromethorphan and its combinatory formulation dextromethorphan/bupropion: a pharmacologic perspectiveYang Jing Zheng, Christine E Dri, Sabrina Wong, et al.Journal of Psychiatric Research|February 16, 2025
The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic reviewKyle Valentino, Kayla M Teopiz, William Cheung, et al.Neuroendocrinology|October 30, 2025
A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic IsletsSabrina Wong, Gia Han Le, John Uhlig, et al.Journal of Geriatric Psychiatry and Neurology|May 8, 2025
Evaluating Suicidal Ideation and Anhedonic Symptoms in Obstructive Sleep Apnea Patients with InsomniaHayun Choi, Gia Han Le, Kayla M Teopiz, et al.Asian Journal of Psychiatry|January 31, 2026
Molecular evidence associating GLP-1 receptor agonists and brain-derived neurotrophic factors in neurodegenerative and psychiatric disorders: A systematic reviewTianyi Xu, Yang Jing Zheng, Sabrina Wong, et al.Journal of Psychopharmacology (Oxford, England)|June 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic reviewShreya Vasudeva, Gabrielle F M Lovell, Sabrina Wong, et al.Pageof 11